ロード中...
Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
Hepatocellular carcinoma (HCC) remains a global medical burden with rising incidence due to chronic viral hepatitis and non-alcoholic fatty liver diseases. Treatment of advanced disease stages is still unsatisfying. Besides first and second generation tyrosine kinase inhibitors, immune checkpoint in...
保存先:
| 出版年: | World J Gastroenterol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6626722/ https://ncbi.nlm.nih.gov/pubmed/31333307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i25.3136 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|